Edward Michael Mccarthy, MD | |
4512 Van Winkle Dr, Amarillo, TX 79119 | |
(806) 358-1497 | |
(806) 358-1375 |
Full Name | Edward Michael Mccarthy |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 25 Years |
Location | 4512 Van Winkle Dr, Amarillo, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902803976 | NPI | - | NPPES |
157344601 | Medicaid | TX | |
157343801 | Medicaid | TX | |
P00005113 | Other | RAILROAD MEDICARE NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | L5831 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Amarillo Dermatology, P.a. | 0749324838 | 2 |
News Archive
News outlets fact-check the bipartisan health care summit and provide analyses of the messaging and poll numbers lawmakers used during the six-hour event.
The New York Times: "The Senate is expected to vote Saturday on whether to take up the legislation. The majority leader, Harry Reid, Democrat of Nevada, refused to say Thursday whether he had the 60 votes needed to clear that procedural hurdle."
As an estimated 2 million Muslims from 184 countries gather in Saudi Arabia's holy city of Mecca to take part in the annual hajj pilgrimage, months of preparations to care for health issues of pilgrims are also coming together.
Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
Carfilzomib significantly improves outcomes in previously treated patients with relapsed or refractory multiple myeloma, shows a head-to-head comparison with bortezomib.
› Verified 8 days ago
Entity Name | Amarillo Dermatology, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619976685 PECOS PAC ID: 0749324838 Enrollment ID: O20100212000130 |
News Archive
News outlets fact-check the bipartisan health care summit and provide analyses of the messaging and poll numbers lawmakers used during the six-hour event.
The New York Times: "The Senate is expected to vote Saturday on whether to take up the legislation. The majority leader, Harry Reid, Democrat of Nevada, refused to say Thursday whether he had the 60 votes needed to clear that procedural hurdle."
As an estimated 2 million Muslims from 184 countries gather in Saudi Arabia's holy city of Mecca to take part in the annual hajj pilgrimage, months of preparations to care for health issues of pilgrims are also coming together.
Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
Carfilzomib significantly improves outcomes in previously treated patients with relapsed or refractory multiple myeloma, shows a head-to-head comparison with bortezomib.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Edward Michael Mccarthy, MD 4512 Van Winkle Dr, Amarillo, TX 79119 Ph: (806) 358-1497 | Edward Michael Mccarthy, MD 4512 Van Winkle Dr, Amarillo, TX 79119 Ph: (806) 358-1497 |
News Archive
News outlets fact-check the bipartisan health care summit and provide analyses of the messaging and poll numbers lawmakers used during the six-hour event.
The New York Times: "The Senate is expected to vote Saturday on whether to take up the legislation. The majority leader, Harry Reid, Democrat of Nevada, refused to say Thursday whether he had the 60 votes needed to clear that procedural hurdle."
As an estimated 2 million Muslims from 184 countries gather in Saudi Arabia's holy city of Mecca to take part in the annual hajj pilgrimage, months of preparations to care for health issues of pilgrims are also coming together.
Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
Carfilzomib significantly improves outcomes in previously treated patients with relapsed or refractory multiple myeloma, shows a head-to-head comparison with bortezomib.
› Verified 8 days ago
Dr. Jason Kyle Jones, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4302 Wolflin Ave, Amarillo, TX 79106 Phone: 806-355-9866 | |
Summer Clark, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1611 Wallace Blvd, Amarillo, TX 79106 Phone: 063-544-9008 | |
Dr. William Robert East, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1901 Medi-park, Suite 6, Amarillo, TX 79106 Phone: 806-355-7421 Fax: 806-358-2381 | |
Christi Anne Baker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4302 Wolflin Ave, Amarillo, TX 79106 Phone: 806-355-9866 Fax: 806-355-4004 | |
Elaine Remmers Cook, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2609 Wolflin Vlg, Amarillo, TX 79109 Phone: 806-358-1117 | |
Dr. Tyler Enos, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4302 Wolflin Ave, Amarillo, TX 79106 Phone: 806-355-9866 | |
Dr. James Keith Yeary, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 Fax: 806-468-1513 |